$VUZI “Broad Street Alerts” Vuzix Corp Newsletter 11:31:05 AM December 16, 2020

on December 16, 2020 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Broad Street Alerts"

The following three charts can be used by potential investors to gauge the performance of "Broad Street Alerts":

0%

0 out of 1 campaigns closed down on first day

100%

1 out of 1 campaigns closed up on first day

0%

0 out of 1 campaigns had no net effect

VUZI Promotional Newsletter

The following is a newsletter released by "Broad Street Alerts" promoting Vuzix Corp

Caution

The following newsletter has not been verified for accuracy or completeness.

Smart glasses may soon be everywhere

Will Vuzix VUZI Smart Glasses Usage Become Ubiquitous in the Healthcare Sector

Applications are coming fast for the M400 VUZI product. Plug Power is now onboard.

Good day everyone,

We are continuing coverage of Vuzix Corporation NASDAQ VUZI, a supplier of Smart-Glasses and Augmented Reality AR technologies and products for the consumer and enterprise.

Current price $6.50 per share up over 34% so far.

VUZI shares got off to an explosive start in yesterdays session.

VUZI is going to present an industry viewpoint on the use of AR glasses in the healthcare system. The company has seen growth in the use of their M400 Smart Glasses at hospitals around the world. The ability for physicians to look in on a procedure or patient remotely has proved to be beneficial.

Surgeries can be broadcast remotely, in real time with detail and viewed from anywhere. The company presentation will take place at the VRARA Healthcare Forum being held virtually today, December 16, 2020 beginning at 1200 PM EST.

Lets look at some applications in healthcare that are currently being improved or reimagined by VUZI smart glasses

Training for hospital functions
Virtual rounds in in ICUs
Triage in emergency rooms
Operating rooms to guide surgeons
Train and mentor doctors remotely
Communication with isolated patients Covid-19

Applications within the healthcare industry may become a significant vertical for VUZI. We mentioned the current applications for VUZI smart glasses in the healthcare setting, but can you imagine entering a hospital where half the staff are wearing VUZI smart glasses

Healthcare has emerged as an important sector for AR smart glasses and we look forward to sharing our perspective on the healthcare industry along with actual deployments and use cases of smart glasses within it, said Paul Travers, President and Chief Executive Officer at Vuzix.

In the next few months, Vuzix will be supporting the release of , which is focused on enhanced medical augmented reality to support the patient success rate including the EMS journey from pre-incident to recovery, powered by Verizon's 5G Ultra-Wideband network for first responders and public safety officials.

We think the applications within the healthcare sector could be virtually endless. Most of us have made a trip to the emergency room, either for ourselves or taking a family member there. Its usually a long process and you are not likely to see a doctor for an hour and then you may end up seeing multiple doctors.

Can you imagine walking into the emergency room and doctors have eyes on you remotely, beginning the moment you get there If your ER visit required an ambulance, doctors could see you during your trip to the hospital. And when a doctor comes to examine you several other professionals are viewing you simultaneously. Could that kind of process greatly reduce the time spent in emergency rooms

MarketsandMarkets has published a research report on the . They expect it will grow to $77.0 billion by 2025, indicating a CAGR of 38.1%. The report highlighted the use of AR Head Mounted Displays, such as VUZI smart glasses, in healthcare including pre-hospital medical care, nursing care in clinical environments, and medical treatment in hospitals along with usage outside of hospitals such as helping with casualties in mass accidents and disasters.

BREAKING NEWS

VUZI has just announced that , a leading provider of hydrogen engines and fueling solutions for enabling e-mobility, has developed and successfully deployed an AR smart glasses-based remote training and onboarding program utilizing Vuzix M400 Smart Glasses powered by Ubimax Frontline.

We turned to Vuzix and Ubimax soon after the COVID-19 pandemic arrived to help solve operational challenges related to onboarding and training our technicians, commented Chris Suriano, Plug Power Vice President of Service.

VUZI smart glasses are being used in several applications such as warehousing, defense industries, training, remote inspections, and healthcare. We believe VUZI smart glasses may become ubiquitous in the healthcare sector being utilized by nurses, doctors, hospitals, surgeons, and many others and could be a huge revenue generator for the company.

It appears that software developers are now designing applications for industry utilizing VUZI smart glasses. Isnt that how Microsoft and Apple got big

The time for explosive revenue growth for VUZI could be right around the corner.

The Team

original VUZI reports below
Verizon 5G- enable EMS to be Supported by Vuzix VUZI Smart Glasses

Good day everyone,

We are continuing coverage of Vuzix Corporation NASDAQ VUZI, a supplier of Smart-Glasses and Augmented Reality AR technologies and products for the consumer and enterprise.

Current price $5.44 12% per share

VUZI shares came out strong in todays session, quickly moving to a high of $5.44share. In the first hour of trading, volume exceeded the daily average volume.

2020 has been a challenging year for many businesses, but it also has opened the door for new innovative technologies like Smart Glasses. In 2020, VUZI smart glasses have gone from a concept for utilization in the healthcare sector, to a reality with deployments across the healthcare spectrum.

VUZI is going to present an industry viewpoint on the use of AR glasses in the healthcare system. The company presentation will take place at the VRARA Healthcare Forum being held virtually tomorrow, December 16, 2020 beginning at 1200 PM EST.

We believe that a large part of the VUZI success story may take place in the healthcare sector and we will focus on that in our full report coming soon.

In the next few months, Vuzix will be supporting the release of Verizon's 5G-enabled EMS, which is focused on enhanced medical augmented reality to support the patient success rate including the EMS journey from pre-incident to recovery, powered by Verizon's 5G Ultra-Wideband network for first responders and public safety officials.

Imagine the value in doctors being able to view a patient in the ambulance on the way to a hospital. In healthcare, minutes are crucial to patient outcomes, particularly in the earliest moments.

The VUZI phenomenon is taking place worldwide, and the company has established offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. Vuzix holds 179 patents and patents pending and numerous IP licenses in the Video Eyewear field.

Note the trend in VUZI shares in the , as well as the bullish moves happening now.

The Team
This week's original report below
Smart Glasses Are Our Reality. As the Augmented Reality AR markets continue to grow, smart glasses may soon be everywhere.

Broad Street Alerts Disruptive Technology Report

A New Way to Communicate is on the Horizon and Industry is Eager to Use it.

Good day everyone,

The broad-based adoption of smart glasses within industry has begun, and its growing fast.

We are continuing coverage of Vuzix Corporation NASDAQ VUZI, a supplier of Smart-Glasses and Augmented Reality AR technologies and products for the consumer and enterprise.
Current price $4.87 per share
Outstanding est. 39.3 million shares
Float est. 34.6 million shares
Insider Holdings 12.99%
Institution Holdings 15.99%

The last time we reported on VUZI was early September and late July. We want to talk about VUZI again for a couple reasons.

First, VUZI shares are trending. It started a month ago and they have continued an uptick ever since. The company shows the trend line in the share price. VUZI shares have broken through their 200 DMA of $3.11 and their 50 DMA of $4.19 in a bullish manner. All levels of the Simple Moving Average are green.

We believe the trend in the company shares may lead to a near term breakout because of the second reason we are reporting today the company has expanded in terms of sales and technology, is working with dozens of the biggest companies in the US on product development and has become more entrenched in the medical sector.

Lets review recent development at VUZI that we believe are contributing to the trend in the companys shares

Revenues for the first three quarters of 2020 are $7.34M. Sales for the FYE December 31, 2019 were $6.67M. The analysts are projecting revenues for FYE 2021 at $18.2M.

Last week, began using Vuzix M400 Smart Glasses to assist field operators performing plant inspections remotely. The ability to use smart glasses for site inspection could save the company time and travel expenses over the current method of sending inspectors to remote construction sites.

Back in August, we reported that , a France-based medical company, had performed the first knee replacement utilizing VUZI M400 Smart Glasses. Pixee has now completed 40 knee replacements utilizing M400 Smart Glasses. They are buying more units.

Vuzix made changes to improve a more comfortable use of Zoom Video Communications Inc. through its . The app provides the Smart Glasses with voice control which allows users to enter meetings by using their voice, voice-to-text dictation.

Vuzix has recently for M400 Smart Glasses from Dutch medical services company, 1Minuut Innovation. 1Minuut is trailblazing within the health care industry through the creation and evolution of their Genzõ mobile platform and now with our M400 Smart Glasses, to deliver new telemedicine experiences, said Paul Travers, Vuzix President and Chief Executive Officer.

The COVID-19 pandemic has become a catalyst for much broader acceptance of enterprise smart glasses, resulting in shorter evaluation periods and increased customer adoption, said Paul Travers, President, and CEO of Vuzix.

When you do your due diligence, you can discover several more recent developments in the VUZI M400 Smart Glasses program.

Vuzix has 179 patents and patents pending. The Company won Consumer Electronics Show CES awards for innovation from 2005 to 2020, fifteen years in a row.

942020 Craig Hallum Boost Target Buy $6.00 $8.00
852020 Bradley Woods Reiterated Buy -
5132020 Maxim Group Reiterated Buy -

Vuzix Products

Ergonomic, durable and built for enterprise environments. Vuzix Product Line

The Vuzix M400 has an obvious advantage in this space as one of the first adopted for use in industry and healthcare around the globe.

Best AR smart-glasses Vuzix Blade Upgraded

The Blade AR is one of the best moves toward mainstream AR glasses weve seen yet. The best bit Vuzix has worked to lower the price from the original $1800 down to below $1,000, just like it said it would.
-source wareable.com

VUZI is a key leader in smart-glasses technology and development. Industries across the globe are really starting to see the benefits of utilizing VUZI products.

We will have an updated report on Vuzix soon.

Stay tuned and stay informed,

The Team

Privacy Policy and Disclaimer

Your Consent

By using our site, you consent to our online privacy policy and disclaimer.

Do we disclose any information to outside parties

We do not sell, trade, or otherwise transfer to outside parties your personally identifiable information.

What information do we collect

We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.

When registering on our site, as appropriate, you may be asked to enter your e-mail address and or mobile number.

What do we use your information for

When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.

Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.

We send periodic emails

The email address you provide may be used to send you information, respond to inquiries, andor other requests or questions.

How do we protect your information

We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.

Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act. We therefore will not distribute your personal information to outside parties without your consent.

Online Privacy Policy Only

This online privacy policy applies to information collected through our website and social media platforms.

Contacting Us

If there are any questions regarding this privacy policy or disclaimer you may reply to this email.

DISCLAIMER

This websitenewsletter is a wholly owned subsidiary of Small Cap Specialists LLC, herein referred to as SCS LLC.

Our reportsreleases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our emailblog list as well as any social networking platforms we may use.

PLEASE NOTE WELL SCS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability Through use of this website viewing or using you agree to hold SCS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury monetary or otherwise that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SCS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. SCS LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and SCS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions quote may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, SCS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. SCS LLC has been compensated twenty three thousand three hundred thirty three dollars cash via bank wire by legends media llc for this weeks coverage of vuzi. The advertisements in this website are believed to be reliable, however, SCS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SCS LLC is not responsible for any claims made by the companies advertised herein, nor is SCS LLC responsible for any other promotional firm, its program or its structure.
SCS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA.

Copyright 2020 Broad Street Alerts,